Related Experiment Video
Updated: Jul 2, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
A clinical evaluation of the Janus Web Application, a software screening tool for drug-drug interactions
Buster Mannheimer1, Johanna Ulfvarson, Sara Eklöf
1Department of Internal Medicine, Karolinska Institutet, Södersjukhuset, SE-11883, Stockholm, Sweden. buster.mannheimer@sodersjukhuset.se
Purpose:
To evaluate the clinical relevance of the Janus Web Application (JWA) in screening for potential drug-drug interactions (DDIs).
Methods:
One hundred and fifty patients taking two drugs or more were studied. Potential DDIs were identified by the JWA. Interviewing the patient and looking into his/her medical records provided complementing information. A clinical pharmacologist judged which potential DDIs were clinically relevant. Potentially relevant DDIs identified by the JWA were then correlated with clinically relevant DDIs.
Results:
A total of 150 significant potential DDIs were found. Sixteen percent (24/150) were judged to be clinically relevant.
Conclusions:
A very small proportion of DDIs was considered clinically relevant in the specific clinical context. To optimise the software's user-friendliness, the following points need to be considered: the possibility of eliminating trivial potential DDIs, individualising drug alerts, and providing written information, accessible via a hyperlink.
Related Concept Videos
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Quantitative Aspects of Drug-Receptor Interaction
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring: Affecting Factors
Drug toxicity: Drug–Drug Interaction
Therapeutic Drug Monitoring: Drug Analysis Methods
